3 Reasons Dividend Stock Teva Pharmaceutical Industries Ltd. Could Fall
Teva Pharmaceutical Industries has been on a nice bull run for the past year. Here are three reasons why this trend might be about to reverse.
3 Reasons Actavis plc Stock Could Fall
Shares of specialty drugmaker Actavis have been ripping higher over the past two years. Here are three reasons why this trend could be coming to an end.
COPD Occurs Most Often in These 5 States
COPD affects more than 6% of the U.S. population and costs $50 billion in direct and indirect costs annually, but these five states have the highest occurrence rate in the country.
Teva Pharmaceuticals New Drug Aims to Reduce Asthma Attacks
Teva Pharmaceutical's reslizumab may some day offer a new treatment option for moderate and severe asthma patients.
Is It Time to Buy Hospira, Inc.'s Stock?
Hospira has had a great run over the past 12 months. Is it time to buy or sell this high-flying stock?
Is It Time to Buy Actavis plc Stock?
Shares of specialty drugmaker Actavis have been hitting all-time highs lately. With an acquisition-fueled revenue bonanza taking place, is it time to buy shares of this red-hot biopharma?